Form 4: Lemaitre Vascular Executive Reports Stock Transactions Following Vesting of Equity Awards
SEC Form 4 Filing
Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, reports stock transactions related to the vesting of restricted stock units and performance stock units.
Summary
- Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular, reported several transactions involving the company's common stock.
- These transactions occurred on December 11th and 12th, 2024, and are related to the vesting of restricted stock units and performance stock units.
- The transactions include the acquisition of shares upon the release of dividend equivalent rights and the withholding of shares to cover tax obligations.
- On December 11th, 7 shares were acquired at $0 due to dividend equivalent rights and 88 shares were sold at $101 to cover tax obligations.
- On December 12th, 10 shares were acquired at $0 due to dividend equivalent rights and 178 shares were sold at $100.28 to cover tax obligations.
- The reported transactions resulted in a net decrease of 169 shares held by the reporting person.
Sentiment
Score: 5
Explanation: The document is a routine filing of stock transactions related to executive compensation. It does not indicate any positive or negative sentiment.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the standard practice of granting equity-based compensation and the subsequent tax obligations.
Comparison to Industry Standards
- The vesting of restricted stock units and performance stock units is a common practice in executive compensation across various industries.
- The withholding of shares to cover tax obligations is also a standard procedure to simplify tax reporting for employees.
- The reported transactions are consistent with typical insider trading activity related to equity compensation.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they represent a small portion of the total outstanding shares.
- The transactions are part of the executive compensation plan and do not indicate any significant change in the company's operations or financial health.
Key Dates
| Date | Description |
|---|---|
| 12/11/2021 | Date of restricted stock unit award that triggered some of the reported transactions. |
| 12/12/2022 | Date of restricted stock unit and performance stock unit awards that triggered some of the reported transactions. |
| 12/11/2024 | Date of some of the reported stock transactions. |
| 12/12/2024 | Date of some of the reported stock transactions. |
| 12/13/2024 | Date the Form 4 was signed. |
Keywords
stock transactions, Form 4, Lemaitre Vascular, insider trading, restricted stock units, performance stock units, dividend equivalent rights, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.